vTv Therapeutics (VTVT) Other Non Operating Income (2014 - 2026)
vTv Therapeutics recorded quarterly Other Non Operating Income of $24000.0 in Q1 2026, up 134.29% quarter-over-quarter from -$70000.0 in Q4 2025, and up 241.18% year-over-year from $7034.5 in Q1 2025.
vTv Therapeutics' Other Non Operating Income history runs 11 years deep, the most recent figure standing at $24000.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income rose 241.18% year-over-year to $24000.0; the TTM figure through Mar 2026 stood at $2000.0 (up 101.69% YoY), while the FY2025 annual figure was -$109000.0, up 27.33% from the prior year.
- Other Non Operating Income came in at $24000.0 for Q1 2026 at vTv Therapeutics, up from -$70000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $725000.0 in Q4 2022 to a low of -$3.6 million in Q3 2023.
- A 5-year average of -$392588.2 and a median of -$6000.0 in 2025 frame the typical range for Other Non Operating Income.
- On a YoY basis, Other Non Operating Income climbed as much as 471.7% in 2023 and fell as far as 1023.46% in 2023.
- vTv Therapeutics' Other Non Operating Income stood at $725000.0 in 2022, then slumped by 76.83% to $168000.0 in 2023, then plunged by 282.74% to -$307000.0 in 2024, then soared by 77.2% to -$70000.0 in 2025, then surged by 134.29% to $24000.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $24000.0, -$70000.0, and -$6000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | vTv Therapeutics | 413.85 Mn | 413.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24,000.00 |
| Dec 31, 2025 | -70,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Jun 30, 2025 | 54,000.00 |
| Mar 31, 2025 | -17,000.00 |
| Dec 31, 2024 | -307,000.00 |
| Sep 30, 2024 | 85,000.00 |
| Jun 30, 2024 | 121,000.00 |
| Mar 31, 2024 | -371,000.00 |
| Dec 31, 2023 | 168,000.00 |
| Sep 30, 2023 | -3.64 Mn |
| Jun 30, 2023 | 303,000.00 |
| Mar 31, 2023 | -238,000.00 |
| Dec 31, 2022 | 725,000.00 |
| Sep 30, 2022 | -324,000.00 |
| Jun 30, 2022 | 53,000.00 |
| Mar 31, 2022 | -3.23 Mn |
| Dec 31, 2021 | 634,000.00 |
| Sep 30, 2021 | -1.08 Mn |
| Jun 30, 2021 | 2.90 Mn |
| Jun 30, 2019 | 1,000.00 |
| Sep 30, 2018 | 10,000.00 |
| Mar 31, 2018 | 36,000.00 |
| Dec 31, 2016 | -24,000.00 |
| Sep 30, 2016 | 2,000.00 |
| Jun 30, 2016 | 1,000.00 |
| Mar 31, 2016 | -1,000.00 |
| Dec 31, 2015 | 13,000.00 |
| Sep 30, 2015 | -1,000.00 |
| Jun 30, 2015 | -1.51 Mn |
| Mar 31, 2015 | 660,000.00 |
| Dec 31, 2014 | -492,000.00 |
| Sep 30, 2014 | -25,000.00 |
| Jun 30, 2014 | 6,000.00 |